MATERIALISE NV

Materialise is a leading provider of additive manufacturing and medical software tools, and sophisticated 3D printing services. The company empowers customers to use additive manufacturing technology more effectively and enables specific applications. Materialise also seeks to empower the choice for sustainability through additive manufacturing. Customers for general software tools and 3D printing services operate in industries such as healthcare, automotive, aerospace, art and design, and consumer products. The significant additive manufacturing applications Materialise is deeply involved in include orthopedic, cranio maxillo facial, eyewear, footwear, and measurement fixtures. As of December 31, 2025, the team consisted of 2,556 full-time equivalents (FTEs) and fully dedicated consultants. The intellectual property portfolio featured 529 issued patents and 128 pending patent applications as of December 31, 2025. For the year ended December 31, 2025, Materialise generated 267.6 million of revenue, a 0.3% increase over the prior year, a net profit of 7.7 million, an Adjusted EBIT of 10.6 million, and an Adjusted EBITDA of 32.4 million. The growth strategy aims to strengthen the market position in additive manufacturing and expand into areas with high long-term potential. In the Materialise Medical segment, the strategy is applied based on the belief that the growing trend of personalized patient care will boost demand for digital planning tools and personalized medical devices.